MRAS and neoplasm: When we assessed RRAS1, RRAS2 and RRAS3 expression according to tumor type and grade (Figure 3b-d), the expression of RRAS1 and RRAS2, but not that of RRAS3, was significantly stronger in grade I and II tumors than in grade III tumors (p < 0.01).